Oral Vancomycin and Gentamicin for Treatment of Very Early Onset Inflammatory Bowel Disease

Publisher： Karger

E-ISSN： 1421-9867|95|4|310-313

ISSN： 0012-2823

Source： Digestion, Vol.95, Iss.4, 2017-06, pp. : 310-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire with Fire?

By  

Digestion, Vol. 95, Iss. 4, 2017-06 ,pp. : 327-328

Karger

Access to resources Recommend Favorite

Early Inflammatory Bowel Disease: Different Treatment Response to Specific or All Medications?

By  

Digestive Diseases, Vol. 27, Iss. 3, 2009-09 ,pp. : 358-365

Karger

Access to resources Recommend Favorite

Links of Autophagy Dysfunction to Inflammatory Bowel Disease Onset

By  

Digestive Diseases, Vol. 34, Iss. 1-2, 2016-03 ,pp. : 27-34

Karger

Access to resources Recommend Favorite

Growth Retardation in Early-Onset Inflammatory Bowel Disease: Should We Monitor and Treat These Patients Differently?

By  

Digestive Diseases, Vol. 27, Iss. 3, 2009-09 ,pp. : 404-411

Karger

Access to resources Recommend Favorite

Patient’s Perspectives Important for Early Anti-Tumor Necrosis Factor Treatment in Inflammatory Bowel Disease

By  

Digestion, Vol. 79, Iss. 1, 2009-02 ,pp. : 30-35

Karger

Access to resources Recommend Favorite